Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ).
Resmed Inc announced an increase in the number of CHESS Depositary Interests (CDIs) issued over quoted securities, with a net addition of 1,288,180 CDIs in June 2025. This change is attributed to net transfers between CDIs and common stock, as well as activities related to stock options and employee stock plans. The adjustments reflect the company’s ongoing efforts to manage its securities and optimize its capital structure, potentially impacting its market positioning and shareholder value.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$37.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Resmed Inc operates in the healthcare industry, focusing on the development and manufacturing of equipment related to sleep disorders, respiratory care, and other chronic diseases. The company is known for its innovative solutions in sleep apnea therapy and is a significant player in the global market for medical devices.
Average Trading Volume: 1,170,006
Technical Sentiment Signal: Buy
Current Market Cap: A$57.19B
Learn more about RMD stock on TipRanks’ Stock Analysis page.